Nicolas Leupin
Director Técnico/Científico/I+D en NOVOCURE LIMITED .
Fortuna: 1 M $ al 31/05/2024
Origen de la red de primer grado Nicolas Leupin.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Medical Specialties | 20 | |
| Public Company | Biotechnology | 18 | |
10
| Public Company | Pharmaceuticals: Other | 10 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Nicolas Leupin a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal President Chief Tech/Sci/R&D Officer Human Resources Officer | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
| INTERSECT ENT, INC. | Medical/Nursing Services | Director of Finance/CFO Director/Board Member | |
| OPTINOSE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Masters Business Admin | |
| GIMV NV | Investment Managers | Corporate Secretary | |
| CAPMAN OYJ | Financial Conglomerates | Director/Board Member | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Masters Business Admin | |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Oslo | College/University | Doctorate Degree | |
| University of Hannover | College/University | Doctorate Degree | |
| Ghent University | College/University | Graduate Degree | |
| University of Bern | College/University | Doctorate Degree Masters Business Admin | |
| Ben-Gurion University of the Negev | College/University | Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Essex Woodlands Health Ventures UK Ltd. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
NanoPass Technologies Ltd.
 NanoPass Technologies Ltd. Pharmaceuticals: MajorHealth Technology NanoPass Technologies Ltd. develops and manufactures pharmaceuticals. It offers MicronJet needle which is a painless Intradermal Injection. The company was founded by Shuki Yeshurun in 2000 and is headquartered in Ness Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Israel Defense Forces | Sovereign | Corporate Officer/Principal | |
Grandeco Wallfashion Group Belgium NV
 Grandeco Wallfashion Group Belgium NV Home FurnishingsConsumer Durables Grandeco Wallfashion Group-Belgium NV engages in the design and manufacture of wallpapers. Its brands include Wall Fashion, Grandeco Boutique, Deco4Walls, Grandeco Life, and VerticalArt. The company was founded in 1978 and is headquartered in Tielt, Belgium. | Home Furnishings | Director/Board Member | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Founder | |
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Cybro Medical Ltd. | Chief Executive Officer | ||
| Washington University School of Medicine | College/University | Doctorate Degree | |
| MINERVA NEUROSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SURFACE ONCOLOGY, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom. | Medical Distributors | Director/Board Member Director/Board Member | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| MADRIGAL PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
NovoCure GmbH
 NovoCure GmbH Pharmaceuticals: MajorHealth Technology Part of NovoCure Ltd., NovoCure GmbH is a German company that is pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. The company is based in Munich, Germany. The CEOs of the company are Asaf Danziger, Wilhelmus C. M. Groenhuysen. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Cubigo International NV
 Cubigo International NV Internet Software/ServicesTechnology Services Cubigo International NV operates as an digital platform which connects community staff, residents and family members to digitalize common functions with senior living communities. The company was founded in 2011 and is headquartered in Hasselt, Belgium. | Internet Software/Services | Director/Board Member | |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Pharmaceuticals: Major | Founder Director/Board Member | |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| NUVATION BIO INC. | Biotechnology | Founder Director/Board Member | |
| Viginti AS | Director/Board Member | ||
Finimmo
 Finimmo Miscellaneous Commercial ServicesCommercial Services Finimmo provides professional corporate and fund administration services. The company is based in Poperinge, Belgium. The Belgian company is a subsidiary of Cofinimmo, which is ultimately controlled by the Government of Belgium. The CEOs are Philippines Maekelberg, Joke Deroo. The company was founded in 2001. | Miscellaneous Commercial Services | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 25 |
| Bélgica | 7 |
| Israel | 6 |
| Reino Unido | 5 |
| Noruega | 5 |
Sectorial
| Health Technology | 28 |
| Consumer Services | 9 |
| Finance | 6 |
| Health Services | 3 |
| Government | 2 |
Operativa
| Director/Board Member | 233 |
| Corporate Officer/Principal | 91 |
| Independent Dir/Board Member | 79 |
| Undergraduate Degree | 30 |
| Chairman | 27 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Göran Albert Ando | 44 |
| Bill Doyle | 38 |
| Tony Vernon | 34 |
| Petri T. Vainio | 24 |
| David Hung | 24 |
| Anthony Adam Rosenberg | 23 |
| John Paul de Koning | 21 |
| Sandipkumar S. Kapadia | 19 |
| Pamela Klein | 19 |
| Jeryl Hilleman | 19 |
| Michael Vasconcelles | 17 |
| Andreas Emmenegger | 14 |
| Timothy Scannell | 14 |
| James Daly | 13 |
| Kin Yip Leung | 11 |
- Bolsa de valores
- Insiders
- Nicolas Leupin
- Conexiones Empresas
